Who is the CEO of ATYR? | Glauxie AI

Q: Who is the CEO of ATYR?

aTyr Pharma, Inc. (ATYR) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Sanjay S. Shukla. aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. Its lead therapeutic candidate is... Employees: 58.

Q: What does ATYR company do?

Learn what ATYR does — business model, products, services, revenue segments, and company history.

Q: Are insiders buying or selling ATYR?

Track recent insider buys and sells for ATYR with transaction details, amounts, and trends.

Q: What sector is ATYR in?

Find ATYR sector, industry, and sub-industry classification with sector peer comparison.

Who is the CEO of ATYR?

🦉

aTyr Pharma, Inc. (ATYR)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOSanjay S. Shukla

aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. Its lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase III clinical trial for pulmonary sarcoidosis;...

Key Executives

Name	Title
Ashlee Dunston	Director of Investor Relations & Corporate Communications
Dalia R. Rayes	Head of Commercial, Global Efzofitimod Franchise
Danielle Campbell	Vice President of Human Resource
Jill Broadfoot	Chief Financial Officer
Leslie Nangle	Vice President of Research
Nancy E. Denyes Krueger	General Counsel & Corporate Secretary

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

ATYR Profile Financials

What does ATYR company do? Are insiders buying or selling ATYR? What sector is ATYR in?